Slow Capital, Inc. Biomarin Pharmaceutical Inc Transaction History

Slow Capital, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$74.73 - $90.69 $1.44 Million - $1.75 Million	-19,331 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $64,405 - $80,007	887 Added 4.81%	19,331 $1.7 Million
Q3 2020 Nov 04, 2020	BUY	$71.87 - $131.03 $74,169 - $135,222	1,032 Added 5.93%	18,444 $1.4 Million
Q2 2020 Aug 10, 2020	SELL	$79.55 - $124.22 $15,591 - $24,347	-196 Reduced 1.11%	17,412 $2.15 Million
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $51,315 - $69,635	719 Added 4.26%	17,608 $1.49 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $1.09 Million - $1.46 Million	16,889 New	16,889 $1.43 Million
Q3 2019 Nov 07, 2019	SELL	$67.4 - $85.11 $365,240 - $461,211	-5,419 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$80.35 - $93.9 $138,925 - $162,353	-1,729 Reduced 24.19%	5,419 $464,000
Q1 2019 May 16, 2019	BUY	$84.2 - $98.62 $14,314 - $16,765	170 Added 2.44%	7,148 $635,000
Q4 2018 Jan 30, 2019	BUY	$80.14 - $106.07 $129,025 - $170,772	1,610 Added 29.99%	6,978 $594,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $21,225 - $23,892	226 Added 4.4%	5,368 $521,000
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $100,561 - $131,016	-1,323 Reduced 20.46%	5,142 $484,000
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $34,019 - $40,571	-438 Reduced 6.35%	6,465 $524,000
Q4 2017 Feb 15, 2018	BUY	$80.76 - $95.13 $557,486 - $656,682	6,903	6,903 $615,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Slow Capital, Inc. with notifications on news.